Respiratory Disease Center, Department of Pathology, Otsu Red Cross Hospital, Otsu, Japan.
Ann Thorac Surg. 2013 Sep;96(3):e75-6. doi: 10.1016/j.athoracsur.2013.03.112.
Hepatic hydrothorax is defined as the presence of a pleural effusion in a patient with liver cirrhosis in the absence of cardiopulmonary disease, and it is a devastating complication impairing quality of life in the end stage of liver disease. The management of the effusion is challenging, and chest tube drainage can sometimes cause more serious complications by removing massive amounts of protein-rich fluid. Though the most plausible mechanism is the influx of ascites to the pleural cavity through a small diaphragmatic defect, the defect often cannot be found. Hepatic hydrothorax could be controlled by repairing an invisible defect of the diaphragm. With pneumoperitoneum after intraperitoneal administration of indocyanine green, the defect, clearly dyed green, appeared on the diaphragm. This novel combination technique could be useful for ensuring the surgical repair of an invisible diaphragmatic defect.
肝性胸水是指在没有心肺疾病的情况下,肝硬化患者出现胸腔积液,这是一种严重的并发症,会在肝病终末期降低生活质量。该胸腔积液的处理具有挑战性,胸腔引流管有时会因移除大量富含蛋白的液体而导致更严重的并发症。虽然最合理的机制是通过小的膈疝孔将腹水流入胸腔,但该缺陷通常无法找到。肝性胸水可以通过修复膈疝的隐形缺陷来控制。在腹腔内注射吲哚菁绿后行气腹,膈疝的隐形缺陷会明显染色呈绿色。这种新的联合技术可能有助于确保对隐形膈疝的手术修复。